Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
13.02
-0.40 (-2.98%)
Feb 21, 2025, 4:00 PM EST - Market closed
Arcutis Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -195.54 | -262.14 | -311.46 | -206.36 | -135.68 | -42 | Upgrade
|
| Depreciation & Amortization | 2.53 | 1.52 | 0.93 | 0.45 | 0.12 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.04 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 29.63 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.28 | -6.99 | -2.25 | 3.45 | 0.07 | -0.35 | Upgrade
|
| Stock-Based Compensation | 41.09 | 38.81 | 32.68 | 23.89 | 7.94 | 0.82 | Upgrade
|
| Other Operating Activities | 4.64 | 5.24 | 2.93 | 0.31 | 0.33 | - | Upgrade
|
| Change in Accounts Receivable | -39.52 | -17.35 | -8.46 | - | - | - | Upgrade
|
| Change in Inventory | 0.64 | -5.62 | -7.51 | - | - | - | Upgrade
|
| Change in Accounts Payable | 1.14 | 3.15 | 1.57 | 0.25 | 5.67 | -0.46 | Upgrade
|
| Change in Other Net Operating Assets | 24.64 | -3.68 | 4.23 | 3.38 | 8.46 | -1.05 | Upgrade
|
| Operating Cash Flow | -167.65 | -247.06 | -257.72 | -174.63 | -113.03 | -42.84 | Upgrade
|
| Capital Expenditures | -0.15 | -0.43 | -0.33 | -1 | -0.32 | -0.3 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -22.95 | - | - | - | Upgrade
|
| Investment in Securities | -68.09 | 180.66 | -63.92 | -74.96 | -181.5 | -26.03 | Upgrade
|
| Investing Cash Flow | -68.24 | 180.23 | -87.2 | -75.95 | -181.82 | -26.33 | Upgrade
|
| Long-Term Debt Issued | - | - | 125 | 73.99 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 125 | 73.99 | - | - | Upgrade
|
| Issuance of Common Stock | 262.9 | 101.32 | 178.99 | 209.6 | 298.15 | 0.27 | Upgrade
|
| Other Financing Activities | - | - | -2.19 | -1.64 | - | -1.4 | Upgrade
|
| Financing Cash Flow | 262.9 | 101.32 | 301.8 | 281.95 | 298.15 | 93.1 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.07 | -0.05 | - | - | - | - | Upgrade
|
| Net Cash Flow | 27.07 | 34.45 | -43.12 | 31.37 | 3.29 | 23.94 | Upgrade
|
| Free Cash Flow | -167.8 | -247.49 | -258.05 | -175.62 | -113.35 | -43.13 | Upgrade
|
| Free Cash Flow Margin | -120.98% | -415.20% | -7000.76% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.49 | -3.57 | -4.69 | -3.55 | -3.18 | -23.40 | Upgrade
|
| Cash Interest Paid | 25.84 | 25.45 | 12.64 | 0.14 | - | - | Upgrade
|
| Levered Free Cash Flow | -96.38 | -151.32 | -195.81 | -102.77 | -63.29 | -28.9 | Upgrade
|
| Unlevered Free Cash Flow | -78.02 | -132.75 | -186.03 | -102.77 | -63.29 | -28.9 | Upgrade
|
| Change in Net Working Capital | 7.78 | 21.97 | 7.85 | -2.96 | -14.37 | 2.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.